spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  GenVec 

 HSMN NewsFeed - 2 Sep 2020
NeuroBo Pharmaceuticals Appoints Douglas J. Swirsky to the Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 16 Jun 2015
Cellectar Appoints Industry Veteran Jim Caruso President and Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 30 Jul 2014
Celldex Therapeutics Announces Senior Leadership Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Apr 2013
BioDelivery Sciences Appoints Thomas W. D'Alonzo to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Sep 2012
GenVec Announces Reduction in Workforce
Biopharmaceuticals
 HSMN NewsFeed - 21 May 2012
GenVec Appoints Cynthia Collins as President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Dec 2011
GenVec President and Chief Executive Officer Announces Retirement
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 May 2010
GenVec Announces Resignation of Mark Thornton as Senior Vice President, Product Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jul 2009
Marinus Pharmaceuticals Adds Two Life Sciences Veterans to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jan 2009
GenVec Reduces Costs to Preserve Capital
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 Nov 2008
GenVec Announces Interim Survival Data in Pivotal Trial of TNFerade in Locally Advanced Pancreatic Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Nov 2008
TNFerade(TM) Receives FDA Fast Track Designation for Treatment of Pancreatic Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 27 Nov 2007
BIND Biosciences, Inc. Closes $16M Series B Financing Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Oct 2007
Allozyne, Inc., Closes $30 Million Series B Financing and Appoints Meenu Chhabra as President and Chief Executive Officer
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 24 Sep 2007
Advanced Cell Technology Completes Acquisition of Mytogen, Inc.
Regenerative Medicine Mergers & Acquisitions
 HSMN NewsFeed - 1 Aug 2007
Advanced Cell Technology Enters Into Definitive Merger Agreement With Mytogen, Inc.
Regenerative Medicine Mergers & Acquisitions
 HSMN NewsFeed - 4 Jun 2007
GenVec Announces Update of Safety and Efficacy Data from Pivotal Phase II/III PACT Study of TNFerade(TM) at ASCO
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 Apr 2007
Anaptys Biosciences Names Former Xoma Executive as Chairman and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Apr 2007
Alba Therapeutics Announces Appointment of Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Apr 2007
Synta Pharmaceuticals Corp. Strengthens Oncology Clinical and Commercial Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Feb 2007
Artisan Pharma, Inc. Hires Senior Clinical and Regulatory Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Jan 2007
GenVec Announces First Patient Treated with TNFerade(TM) for Head and Neck Cancer at University of Chicago
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Jan 2007
GenVec Receives Clearance From FDA for EUS Administration of TNFerade(TM)
Biopharmaceuticals Oncology FDA Drug Delivery
 HSMN NewsFeed - 19 Dec 2006
GenVec Announces Efficacy Update in Phase II/III Clinical Trial of TNFerade(TM) in Locally Advanced Pancreatic Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Dec 2006
GenVec Announces Completion of Interim Safety Data Analysis for Phase II/III Trial with TNFerade(TM) in Pancreatic Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Nov 2006
Symphogen Appoints Christian Meyer Vice President of Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Oct 2006
GenVec Names Mark O. Thornton, MD, MPH, PhD as Senior Vice President, Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Sep 2006
GenVec Names Douglas J. Swirsky as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Sep 2006
Stelios Papadopoulos to Resign from GenVec's Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 May 2006
Celldex appoints Thomas Davis, M.D as Chief Medical Officer and Tibor Keler, Ph.D as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 May 2006
Long-Term Results from TNFerade(TM) Pancreatic Cancer Study and Updated Survival Results from TNFerade(TM) Esophageal Cancer Study Both Reported at Digestive Disease Week
Biopharmaceuticals Oncology
Return to NewsFeed  

 Additional items found! 43

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 43 additional stories matching:
GenVec
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.